Skip to main content
. 2024 Feb 16;101:105009. doi: 10.1016/j.ebiom.2024.105009

Table 8.

Differences in the total costs and quality of life in both the PGx-guided and the control study arms.

PGx-guided arm
Control arm
QALYa Total cost (€)a QALYa Total cost (€)a
Schizophrenia 0.9697 1243 0.9768 1115
Major depressive disorder 0.935 1302 0.925 2526
Bipolar Disorder 0.96 940 0.97 1027

The data have been calculated using bootstrapping analysis.

a

Refers to average values.